Ligand · 359
359 · 3-[[3-[(2R)-3-[[(2S)-5-amino-1-[(4-carbamimidoylphenyl)methylamino]-1,5-dioxo-pentan-2-yl]amino]-2-(ethylsulfonylamino)-3-oxo-propyl]-1H-indol-5-yl]oxymethyl]benzoic acid
359, 3-[[3-[(2R)-3-[[(2S)-5-amino-1-[(4-carbamimidoylphenyl)methylamino]-1,5-dioxo-pentan-2-yl]amino]-2-(ethylsulfonylamino)-3-oxo-propyl]-1H-indol-5-yl]oxymethyl]benzoic acid (C34 H39 N7 O8 S, 705.8 g/mol), in the MolNFT structures on…
- Component
- 359
- Formula
- C34 H39 N7 O8 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
359 in 2 structures; the first of them:
- 2ZZU · Human Factor VIIA-Tissue Factor Complexed with… · 359 H1 · binds HIS57, ASP60, TYR94, PRO96, GLY97, THR98, THR99, ASP170G and 15 more
- 2ZZU · Human factor viia-tissue factor complexed with ethylsulfonamide-D-5… · 359 H1 · binds HIS57, ASP60, TYR94, PRO96, GLY97, THR98, THR99, ASP170G and 15 more
Residues it binds most
GLY 2, SER 2, ASP 2, CYS 2, PRO 2, THR 2, GLN 2, HIS 2, LYS 2, TRP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.